Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about disclosures

03 Jul 2026 Evaluate
Ajanta Pharma has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1869.50
Dr. Reddys Labs. 1370.40
Cipla 1394.00
Lupin 1977.90
Zydus Lifesciences 1200.25
View more..